Trademark: 97342595
Status Date
Wednesday, November 29, 2023
Filing Date
Friday, April 1, 2022
Published for Opposition
Tuesday, February 21, 2023
Abandoned Date
Monday, November 20, 2023
5 Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
Nov 29, 2023
Abandonment Notice E-Mailed - Failure To Respond
Nov 29, 2023
Abandonment Notice Mailed - Failure To Respond
Nov 29, 2023
Abandonment - Failure To Respond Or Late Response
Aug 16, 2023
Application Extension Granted/Receipt Provided
Aug 16, 2023
Application Extension To Response Period - Received
Jun 1, 2023
Teas Change Of Owner Address Received
Jun 1, 2023
Teas Change Of Correspondence Received
Jun 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
May 17, 2023
Notification Of Non-Final Action E-Mailed
May 17, 2023
Non-Final Action E-Mailed
May 17, 2023
Su - Non-Final Action - Written
May 17, 2023
Statement Of Use Processing Complete
Apr 26, 2023
Use Amendment Filed
May 16, 2023
Case Assigned To Intent To Use Paralegal
Apr 26, 2023
Teas Statement Of Use Received
Apr 18, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 21, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2023
Published For Opposition
Feb 1, 2023
Notification Of Notice Of Publication E-Mailed
Jan 18, 2023
Approved For Pub - Principal Register
Jan 18, 2023
Examiner's Amendment Entered
Jan 18, 2023
Notification Of Examiners Amendment E-Mailed
Jan 18, 2023
Examiners Amendment E-Mailed
Jan 18, 2023
Examiners Amendment -Written
Jan 9, 2023
Assigned To Examiner
Apr 6, 2022
New Application Office Supplied Data Entered
Apr 5, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
